We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App

New AI Tool to Help Combat Future COVID Variants

By HospiMedica International staff writers
Posted on 13 Dec 2021
Print article

A new artificial intelligence (AI) tool makes it possible to predict the structure of proteins faster, which is crucial for developing vaccines against coronavirus variants of the future.

Researchers from the University of Copenhagen (Copenhagen, Denmark) and Evaxion Biotech (Copenhagen, Denmark) are behind the new tool that aims to pave the way for a vaccine that can prevent new pandemics. In order to prevent further severe pandemics, the researchers teamed up to develop a new AI tool that can more quickly and effectively predict how different protein elements can be assembled to increase the likelihood of coronavirus protection. Their tool, BIFROST, is a computer model that uses algorithms to put together virus proteins that are most likely to be included in a vaccine.

BIFROST uses data on amino acid chains – the building blocks of proteins – to predict how various proteins look and behave. In the future, this knowledge will allow researchers to design "super proteins" that elicit the desired response to viruses in the immune system, with few side effects. BIFROST has numerous advantages over other models used to learn about the shape and behavior of proteins. BIFROST is equipped to provide us with more suggestions about potential protein shapes and behaviors. This is important when trying to develop a vaccine that needs to be able to recognize many new variants of, for example, coronavirus spike proteins.

"The dream scenario is that we can design a coronavirus vaccine that is more effective than those of today and that protects against future corona variants or entirely new viruses. Here, BIFROST is an important step along the way," said Anders B. Sørensen, head of research at Evaxion. "We have proven that BIFROST acts as a concept in the design phase, whereas real-world testing with animal models will be completed in 2022. So there remains a ways to go for us to test how our designed proteins function in humans. Nevertheless, with BIFROST, we have taken an important step towards creating a vaccine that can protect us from future pandemics."

Related Links:
University of Copenhagen 
Evaxion Biotech 

Print article


Critical Care

view channel
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

Barrett's esophagus (BE) is the benign and treatable precursor condition to esophageal adenocarcinomas (EAC) which is usually diagnosed at an advanced stage and is difficult to treat. Finding BE, a sign... Read more

Surgical Techniques

view channel
Image: Novel surface treatment could prevent deadly hospital infections without antibiotics (Photo courtesy of Penn State)

Novel Surface Treatment Stops Microbes from Adhering to Medical Devices

Hospitals and medical clinics can be the source of nasty infections, resulting in death from infection-related complications and billions in direct medical costs. The biggest culprits, experts say - accounting... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.